CELLDEX THERAPEUTICS INC NEW's ticker is CLDXXXXX and the CUSIP is 15117B103. A total of 162 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q4 2013. The put-call ratio across all filers is 0.83 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2015 | $5,018,000 | +61.4% | 320,000 | +8.5% | 0.76% | +53.0% |
| Q3 2015 | $3,109,000 | -37.4% | 295,000 | +49.7% | 0.50% | -16.9% |
| Q2 2015 | $4,968,000 | +49.8% | 197,000 | +65.5% | 0.60% | +6.8% |
| Q1 2015 | $3,317,000 | +3.9% | 119,000 | -32.0% | 0.56% | -39.6% |
| Q4 2014 | $3,194,000 | +78.6% | 175,000 | +26.8% | 0.93% | +76.7% |
| Q3 2014 | $1,788,000 | -45.0% | 138,000 | -30.7% | 0.52% | -45.6% |
| Q2 2014 | $3,248,000 | +149.5% | 199,000 | +170.0% | 0.96% | +146.5% |
| Q1 2014 | $1,302,000 | -40.2% | 73,702 | -18.1% | 0.39% | -54.1% |
| Q4 2013 | $2,179,000 | – | 90,000 | – | 0.85% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Byrne Asset Management LLC | 86 | $2,000 | 0.00% |